German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults

Lymphoma, Lymphoblastic Clinical Trial

Official title:
Multicenter Trial for Treatment Optimization in T-lymphoblastic Lymphoma in Adults and Adolescents Older Than 15 Years (GMALL T-LBL 1/2004) (Amend 1)

Status Completed

Clinical Trial Summary

This study evaluates the efficacy and tolerability of treatment for T-lymphoblastic lymphoma (T-LBL) according to a protocol for acute lymphoblastic leukemia. Patients receive one year of intensive cyclical chemotherapy with additional prophylaxis for central nervous system (CNS) relapse by intrathecal therapy and cranial irradiation and mediastinal irradiation after induction chemotherapy.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00199017
Study type	Interventional
Source	Johann Wolfgang Goethe University Hospitals
Contact
Status	Completed
Phase	Phase 4
Start date	April 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00186875` - Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia	Phase 2
Recruiting	`NCT02396043` - Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma	Phase 2
Completed	`NCT00199030` - Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath	Phase 2